Skip to main navigation Skip to search Skip to main content

Alirocumab and cardiovascular outcomes after acute coronary syndrome

  • ODYSSEY OUTCOMES Committees and Investigators
  • , G. G. Schwartz
  • , P. G. Steg
  • , M. Szarek
  • , D. L. Bhatt
  • , V. A. Bittner
  • , R. Diaz
  • , J. M. Edelberg
  • , S. G. Goodman
  • , C. Hanotin
  • , R. A. Harrington
  • , J. W. Jukema
  • , G. Lecorps
  • , K. W. Mahaffey
  • , A. Moryusef
  • , R. Pordy
  • , K. Quintero
  • , Matthew T. Roe
  • , W. J. Sasiela
  • , J. F. Tamby
    • P. Tricoci, Harvey D. White, A. M. Zeiher, Philip E. Aylward, Sam J. Lehman

Research output: Contribution to journal › Article › peer-review

3234 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Alirocumab and cardiovascular outcomes after acute coronary syndrome'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science